| Resolor (prucalopride) / J&J, Takeda |
2022-003221-22: A study to determine how safe and effective different doses of prucalopride are in children and teenagers with functional constipation |
|
|
| Not yet recruiting | 3 | 175 | US | Prucalopride, TAK-555, Film-coated tablet, Oral solution | Takeda Development Center Americas, Inc., Takeda Development Center Americas, Inc. | Constipation, Constipation, Diseases [C] - Digestive System Diseases [C06] | | | | |
NCT04759833: A Study of Prucalopride For Functional Constipation in Children and Teenagers |
|
|
| Terminated | 3 | 175 | US | Prucalopride, TAK-555, Prucalopride succinate, Placebo | Takeda, Takeda Development Center Americas, Inc. | Constipation | 11/23 | 11/23 | | |
2011-000308-16: Prucalopride versus placebo in patients with significantly delayed gastric emptying of idiopathic and diabetic nature |
|
|
| Ongoing | 2 | 60 | Europe | Film-coated tablet, Resolor | UZ Leuven, Shire | Patients with delayed gastric emptying (t1/2 for solids ≥ 109 min) either from idiopathic or diabetic origin, delayed gastric emptying (when it takes ≥ 109 minutes before half of a standard solid meal has left the stomach) either from idiopathic or diabetic origin, Diseases [C] - Digestive System Diseases [C06] | | | | |
NCT04961840: A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy |
|
|
| Active, not recruiting | N/A | 100 | US | No Intervention | Takeda | Constipation, Pregnancy | 12/25 | 12/25 | | |
NCT04869280: Post-Marketing Study of Prucalopride Safety In Pregnancy |
|
|
| Recruiting | N/A | 616 | US | No Intervention | Takeda, The Organization of Teratology Information Specialists | Chronic Constipation | 05/26 | 05/26 | | |
NCT04838522: A Study of Prucalopride in Breastfeeding Women With Constipation |
|
|
| Recruiting | N/A | 12 | US | No Intervention | Takeda, UC San Diego Human Milk Research Biorepository | Chronic Constipation | 12/26 | 12/26 | | |